Brainomix to collaborate with U.K. government on AI for lung cancer

By staff writers

October 10, 2022 -- U.K. artificial intelligence (AI) software developer Brainomix plans to collaborate with the National Consortium of Intelligent Medical Imaging (NCIMI) on a 12-month project to validate its automated cancer tracking tool, e-ACT.

e-ACT is an AI-based tool that tracks disease progression and response in lung cancer patients and compares its performance to radiologist readers. The project will also include three National Health Service (NHS) cancer centers in Truro, Bath, and Leeds, and will include CT and clinical data from 200 patients, the company said.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking